Loading...

Incannex Healthcare Limited

IXHL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.03
$0.24(6.33%)
U.S. Market opens in NaNh NaNm

Incannex Healthcare Limited (IXHL) Stock Overview

Explore Incannex Healthcare Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap46.3M
P/E Ratio-0.80
EPS (TTM)$-22.20
ROE-1.99%
Fundamental Analysis

AI Price Forecasts

1 Month$4.05
3 Months$0.17
1 Year Target$0.00

IXHL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Incannex Healthcare Limited (IXHL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.80 and a market capitalization of 46.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
6.33%
5-Day Change
7.47%
1-Month Change
44.96%
3-Month Change
-60.95%
6-Month Change
-61.55%
Year-to-Date (YTD) Change
-62.48%
1-Year Change
-78.51%
3-Year Change
-94.00%
5-Year Change
-99.10%
All-Time (Max) Change
-99.10%

Contact Information

https://www.incannex.com.au
61 4 2570 3805
207/11 Solent Circuit, Sydney, NSW, 2153

Company Facts

9 Employees
IPO DateMar 2, 2022
CountryAU
Actively Trading

Frequently Asked Questions